BIOLINERX LTD-SPONS ADR (BLRX)
US09071M2052 - ADR
BIOLINERX LTD-SPONS ADR
NASDAQ:BLRX (5/3/2024, 7:00:01 PM)
After market: 0.7 +0.02 (+2.94%)0.68
+0.02 (+3.01%)
Company Profile
BioLineRx Ltd. is a clinical stage biopharmaceutical company, which engages in the research and development of treatments that focus on cancer. The firm is commited into in-license novel compounds, develop them through clinical stages, and then partner with pharmaceutical companies for further clinical development andcommercialization. The firm is commited into two projects: Motixafortide (BL-8040), which is a cancer therapy platform , and AGI-134, an immunotherapy treatment.
Company Info
BIOLINERX LTD-SPONS ADR
Modi'in Technology Park, 2 HaMa'ayan Street
Modiin 7177871
P: 97286429100
CEO: Philip A. Serlin
Employees: 49
Website: https://www.biolinerx.com/
BLRX News
a month ago - BioLineRx Ltd.BioLineRx Announces $6 Million Registered Direct Offering/PRNewswire/ -- BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX) ("BioLineRx" or the "Company"), a commercial stage biopharmaceutical company pursuing life-changing...
a month ago - InvestorPlaceBLRX Stock Earnings: BioLine Rx Beats EPS for Q4 2023BLRX stock results show that BioLine Rx beat analyst estimates for earnings per share the fourth quarter of 2023.
a month ago - BusinessInsiderBLRX Stock Earnings: BioLine Rx Beats EPS for Q4 2023InvestorPlace - Stock Market News, Stock Advice & Trading Tips BioLine Rx (NASDAQ:BLRX) just reported results for the fourth quarter of 2023.B...
a month ago - BioLineRx Ltd.BioLineRx Reports 2023 Financial Results and Recent Corporate and Portfolio Updates- Reported significant commercial progress for APHEXDA® -- secured payer coverage representing ~95% of covered lives in the U.S.; continued progress on...
a month ago - BioLineRx LtdBioLineRx to Report 2023 Annual Financial Results on March 26, 2024/PRNewswire/ -- BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a commercial stage biopharmaceutical company pursuing life-changing therapies in oncology and rare...
2 months ago - FinancialNewsMediaBiotech/Oncology Stocks Targeting the Pancreatic Cancer Market – A Race WorthEQNX::TICKER_START (ONASDAQ:ONCY),(TSX:ONC),(NASDAQ:BLRX),(NASDAQ:IMRX),(NASDAQ:CADL) EQNX::TICKER_END
BLRX Twits
Here you can normally see the latest stock twits on BLRX, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits:
